Jump to the Navigation Menu
Login to My AlzForum
Jump to the Search form

Papers

255833 Results

Sort By:

Publication Date
Journal Title
First Author
Most Commented

Go to another page:

9868
9869
9870
9871
9872
... 17056

Send results to Selected: 0 Clear selection

Miller J, Arrasate M, Shaby BA, Mitra S, Masliah E, Finkbeiner S. Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis. J Neurosci. 2010 Aug 4;30(31):10541-50. PubMed.

Miller J, Arrasate M, Brooks E, Libeu CP, Legleiter J, Hatters D, Curtis J, Cheung K, Krishnan P, Mitra S, Widjaja K, Shaby BA, Lotz GP, Newhouse Y, Mitchell EJ, Osmand A, Gray M, Thulasiramin V, Saudou F, Segal M, Yang XW, Masliah E, Thompson LM, Muchowski PJ, Weisgraber KH, Finkbeiner S. Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat Chem Biol. 2011 Dec;7(12):925-34. PubMed.

Miller J, Hanson E, Baerresen K, Miller K, Gottuso A, Ercoli L, Siddarth P, Small G. A-12Screening for Mild Cognitive Impairment (MCI) with the Mini-Mental Status Exam (MMSE) and Rey-Osterrieth Complex Figure Test (ROCF). Arch Clin Neuropsychol. 2014 Sep;29(6):508. PubMed.

Miller JA, Dudley MW, Kehne JH, Sorensen SM, Kane JM. MDL 26,479: a potential cognition enhancer with benzodiazepine inverse agonist-like properties. Br J Pharmacol. 1992 Sep;107(1):78-86. PubMed.

Alzforum Recommends

Miller JA, Oldham MC, Geschwind DH. A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging. J Neurosci. 2008 Feb 6;28(6):1410-20. PubMed.

Included in: News, Webinars

1 Comment
Login to Comment or Recommend

Miller JA, Horvath S, Geschwind DH. Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways. Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12698-703. PubMed.

Included in: News

Miller JA, Woltjer RL, Goodenbour JM, Horvath S, Geschwind DH. Genes and pathways underlying regional and cell type changes in Alzheimer's disease. Genome Med. 2013 May 25;5(5):48. PubMed.

Included in: News

Miller JA, Guillozet-Bongaarts A, Gibbons LE, Postupna N, Renz A, Beller AE, Sunkin SM, Ng L, Rose SE, Smith KA, Szafer A, Barber C, Bertagnolli D, Bickley K, Brouner K, Caldejon S, Chapin M, Chua ML, Coleman NM, Cudaback E, Cuhaciyan C, Dalley RA, Dee N, Desta T, Dolbeare TA, Dotson NI, Fisher M, Gaudreault N, Gee G, Gilbert TL, Goldy J, Griffin F, Habel C, Haradon Z, Hejazinia N, Hellstern LL, Horvath S, Howard K, Howard R, Johal J, Jorstad NL, Josephsen SR, Kuan CL, Lai F, Lee E, Lee F, Lemon T, Li X, Marshall DA, Melchor J, Mukherjee S, Nyhus J, Pendergraft J, Potekhina L, Rha EY, Rice S, Rosen D, Sapru A, Schantz A, Shen E, Sherfield E, Shi S, Sodt AJ, Thatra N, Tieu M, Wilson AM, Montine TJ, Larson EB, Bernard A, Crane PK, Ellenbogen RG, Keene CD, Lein E. Neuropathological and transcriptomic characteristics of the aged brain. Elife. 2017 Nov 9;6 PubMed.

Miller JB, Banks SJ, Léger GC, Cummings JL. Randomized controlled trials in frontotemporal dementia: cognitive and behavioral outcomes. Transl Neurodegener. 2014;3:12. Epub 2014 Jun 5 PubMed.

Miller JB, Shan G, Lombardo J, Jimenez-Maggoria G. Biomedical informatics applications for precision management of neurodegenerative diseases. Alzheimers Dement (N Y). 2018;4:357-365. Epub 2018 Jun 13 PubMed.

Miller JB, Cummings J, Nance C, Ritter A. Neuroscience learning from longitudinal cohort studies of Alzheimer's disease: Lessons for disease-modifying drug programs and an introduction to the Center for Neurodegeneration and Translational Neuroscience. Alzheimers Dement (N Y). 2018;4:350-356. Epub 2018 Jul 11 PubMed.

Miller JB, Kauwe JS. Predicting Clinical Dementia Rating Using Blood RNA Levels. Genes (Basel). 2020 Jun 26;11(6) PubMed.

Miller JB, Ward E, Staley LA, Stevens J, Teerlink CC, Tavana JP, Cloward M, Page M, Dayton L, Alzheimer's Disease Genetics Consortium, Cannon-Albright LA, Kauwe JS. Identification and genomic analysis of pedigrees with exceptional longevity identifies candidate rare variants. Neurobiol Dis. 2020 Sep;143:104972. Epub 2020 Jun 21 PubMed.

Miller JD, Ganat YM, Kishinevsky S, Bowman RL, Liu B, Tu EY, Mandal PK, Vera E, Shim JW, Kriks S, Taldone T, Fusaki N, Tomishima MJ, Krainc D, Milner TA, Rossi DJ, Studer L. Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell. 2013 Dec 5;13(6):691-705. PubMed.

Included in: News

Miller JE, Shivakumar MK, Risacher SL, Saykin AJ, Lee S, Nho K, Kim D. Codon bias among synonymous rare variants is associated with Alzheimer's disease imaging biomarker. Pac Symp Biocomput. 2018;23:365-376. PubMed.

Go to another page:

9868
9869
9870
9871
9872
... 17056

Current Filters

Remove all filters

Filter By

Papers of the Week

Current Week (288)
5-11 Apr 2024 (270)
29 Mar - 4 Apr 2024 (264)
22-28 Mar 2024 (336)

Type ?

Milestone (286)
Alzforum Recommends (3833)

Publication Range

From
1. Month
2. Year
To
1. Month
2. Year

Background
Methods
FAQ

Enter your keywords

LOGIN
HOME
About Us
Newsletter

NEWS
- All News
- Conference Coverage
WEBINARS
- All Webinars
Databases
- AlzAntibodies
- AlzBiomarker
- AlzPedia
- AlzRisk
- Brain Banks
- Genetics
  - AlzGene
  - HEX
  - Mutations
- Protocols
- Research Models
- Therapeutics
PAPERS
PROFESSIONAL RESOURCES
ABOUT AD
MY ALZFORUM

Back to the Top

Terms of Service
How to Cite
Privacy Policy
Site Map
Contact Us